oral glp-1 agonist approved Semaglutide to Reduce the Risk of Cardiovascular Events Lilly is now pharma's top
Description
Factors that influence cost Whether the medication is prescribed for diabetes or weight loss Brand availability Pharmacy location Dose and frequency General supply and demand Some insurers require patients to try older diabetes medications first
The results from the SUSTAIN 6 trial indicated that patients treated with semaglutide experienced a significantly higher incidence of DR compared to those receiving placebo (86)
doi: 10.1016/S0140-6736(08)61206-4 116 NorwoodPLiutkusJFHaberHPintileiEBoardmanMKTrautmannME
Pancreatitis: In clinical trials, there were more cases of pancreatitis among Victoza-treated patients than among comparator-treated patients
Osteoarthritis (e.g., STEP 9)
Klein A, Stern N, Osher E, Kliper E, Kesler A
